PLUS THERAPEUTICS Enters Material Definitive Agreement
Ticker: PSTV · Form: 8-K · Filed: Oct 21, 2025 · CIK: 1095981
| Field | Detail |
|---|---|
| Company | Plus Therapeutics, Inc. (PSTV) |
| Form Type | 8-K |
| Filed Date | Oct 21, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001, $58,745 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, financial-obligation
TL;DR
PLUS THERAPEUTICS just signed a big deal, creating a new financial obligation. Details in the 8-K.
AI Summary
On October 16, 2025, PLUS THERAPEUTICS, INC. entered into a material definitive agreement. This agreement also created a direct financial obligation for the registrant. The filing includes financial statements and exhibits related to this event.
Why It Matters
This filing indicates a significant new financial commitment or contract for PLUS THERAPEUTICS, INC., which could impact its financial standing and future operations.
Risk Assessment
Risk Level: medium — Entering into new material definitive agreements and financial obligations can introduce financial risks and operational changes that require careful monitoring.
Key Players & Entities
- PLUS THERAPEUTICS, INC. (company) — Registrant
- October 16, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-34375 (filing_id) — SEC File Number
- 33-0827593 (tax_id) — IRS Employer Identification No.
FAQ
What type of material definitive agreement did PLUS THERAPEUTICS, INC. enter into?
The filing states that PLUS THERAPEUTICS, INC. entered into a material definitive agreement, but the specific type of agreement is not detailed in the provided text.
What is the nature of the direct financial obligation created?
The filing confirms the creation of a direct financial obligation for the registrant, but the specific details of this obligation are not provided in the excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on October 16, 2025.
What is the state of incorporation for PLUS THERAPEUTICS, INC.?
PLUS THERAPEUTICS, INC. is incorporated in Delaware.
What are the former names of PLUS THERAPEUTICS, INC. mentioned in the filing?
The filing mentions that the company was formerly known as CYTORI THERAPEUTICS, INC. (name change on 20050712) and MACROPORE INC (name change on 20010320).
Filing Stats: 588 words · 2 min read · ~2 pages · Grade level 9.4 · Accepted 2025-10-21 07:25:20
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 PSTV The Nasdaq Capital Market Ind
- $58,745 — ase provides for a monthly base rent of $58,745, which increases annually by approximat
Filing Documents
- d637082d8k.htm (8-K) — 25KB
- d637082dex101.htm (EX-10.1) — 842KB
- g637082g1016061854670.jpg (GRAPHIC) — 52KB
- 0001193125-25-244275.txt ( ) — 1224KB
- pstv-20251016.xsd (EX-101.SCH) — 3KB
- pstv-20251016_lab.xml (EX-101.LAB) — 18KB
- pstv-20251016_pre.xml (EX-101.PRE) — 11KB
- d637082d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 21, 2025 PLUS THERAPEUTICS, INC. By: /s/ Marc H. Hedrick, M.D. Marc H. Hedrick, M.D. President and Chief Executive Officer